Found 8 matching trials
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
PHASE2This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Location
The First Hospital of Jilin University
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
PHASE1Patients may be considered if the cancer has come back, has not gone away a...
Location
Texas Children's Hospital
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
PHASE1This Phase 1, open-label, non-randomized study will enroll pediatric and yo...
Location
Seattle Children's Hospital
GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)
PHASE1This study is being conducted in patients with GPC3-positive brain tumors t...
Location
Texas Children's Hospital
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors
PHASE1Patients may be considered if the cancer has come back, has not gone away a...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
PHASE1This Phase 1, open-label, non-randomized study will enroll adult subjects w...
Location
Fred Hutch Cancer Center
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
PHASE1Patients may be considered if the cancer has come back, has not gone away a...
Status
Active Not Recruiting
Location
Texas Children's Hospital
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
PHASE1The body has different ways of fighting infection and disease. No single wa...
Location
Houston Methodist Hospital